Company Enzo Biochem, Inc. Deutsche Boerse AG
Equities
EZB
US2941001024
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1 EUR | +0.50% |
|
-.--% | -18.70% |
06-13 | Enzo Biochem, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024 | CI |
03-15 | North American Morning Briefing : Inflation Worries Continue to Weigh on Mood | DJ |
Business Summary
Number of employees: 185
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Life Sciences Products
100.0
%
| 33 | 30.5 % | 31 | 100.0 % | -4.85% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
59.7
%
| 94 | 88.0 % | 19 | 59.7 % | -80.31% |
Europe
27.2
%
| 9 | 8.0 % | 8 | 27.2 % | -1.40% |
Asia Pacific
13.1
%
| 4 | 4.0 % | 4 | 13.1 % | -5.40% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kara Cannon
CEO | Chief Executive Officer | 56 | 31/12/10 |
Elazar Rabbani
FOU | Founder | 81 | 31/07/76 |
Patricia Eckert
DFI | Director of Finance/CFO | 47 | - |
Dieter Schapfel
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/06/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Pully
CHM | Chairman | 64 | 25/10/23 |
Mary Tagliaferri
BRD | Director/Board Member | 58 | 16/11/20 |
Bradley Radoff
BRD | Director/Board Member | 50 | 02/01/22 |
Elazar Rabbani
FOU | Founder | 81 | 31/07/76 |
Kara Cannon
CEO | Chief Executive Officer | 56 | 31/12/10 |
Ian Walters
BRD | Director/Board Member | 57 | 24/11/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,457,660 | 39,064,692 ( 75.92 %) | 0 | 75.92 % |
Company contact information
![address Enzo Biochem, Inc.(EZB)](https://cdn.zonebourse.com/static/address/438392.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- ENZ Stock
- EZB Stock
- Company Enzo Biochem, Inc.